{
    "clinical_study": {
        "@rank": "117485", 
        "acronym": "Li2CO3", 
        "arm_group": [
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "The shape,color and smell of placebo are similar to Lithium Carbonate tablet used in the treatment arm.Patients in this arm take placebo twice a day."
            }, 
            {
                "arm_group_label": "Lithium Carbonate", 
                "arm_group_type": "Experimental", 
                "description": "Patients in this arm take Lithium Carbonate twice a day with a dose of 20-25mg/kg/d."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to determine whether Lithium Carbonate combined with\n      neo-adjuvant chemotherapy improve the prognosis of osteosarcoma"
        }, 
        "brief_title": "Clinical Trial of Lithium Carbonate Combined With Neo-adjuvant Chemotherapy to Treat Osteosarcoma", 
        "completion_date": {
            "#text": "December 2023", 
            "@type": "Anticipated"
        }, 
        "condition": "Osteosarcoma", 
        "condition_browse": {
            "mesh_term": "Osteosarcoma"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  histologically diagnosed primary classical osteosarcoma in extremities\n\n          -  staging IIB\n\n          -  MRI showing no skip lesion\n\n          -  receive standard neo-adjuvant chemotherapy, adjuvant chemotherapy,and standard\n             surgical treatment\n\n        Exclusion Criteria:\n\n          -  a history of non-standard treatment(chemotherapy or surgery)\n\n          -  secondary osteosarcoma or well-differentiated parosteal osteosarcoma\n\n          -  evident dysfunction of cardia,liver and kidney, or pregnant women or women during\n             lactation"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "8 Years"
        }, 
        "enrollment": {
            "#text": "400", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 14, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01669369", 
            "org_study_id": "Lithium-5010"
        }, 
        "intervention": {
            "arm_group_label": "Lithium Carbonate", 
            "intervention_name": "Lithium Carbonate", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Lithium", 
                "Lithium Carbonate"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Lithium Carbonate", 
            "Chemotherapy", 
            "prognosis"
        ], 
        "lastchanged_date": "August 16, 2012", 
        "location": [
            {
                "contact": {
                    "email": "2004wjhf@163.com;viewrine@qq.com", 
                    "last_name": "Jin Wang, PhD", 
                    "phone": "+86-87755766", 
                    "phone_ext": "8236"
                }, 
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong", 
                        "zip": "510080"
                    }, 
                    "name": "The first affiliated hospital,Sun Yat-sen University"
                }, 
                "investigator": {
                    "last_name": "Jin Wang, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jin Wang, PhD", 
                    "phone": "+86-20-87755766", 
                    "phone_ext": "8236"
                }, 
                "facility": {
                    "address": {
                        "city": "Guangzhou", 
                        "country": "China", 
                        "state": "Guangdong", 
                        "zip": "510080"
                    }, 
                    "name": "The first affiliated hospital,Sun Yat-sen University"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_arms": "2", 
        "official_title": "A Prospected Randomized Multi-center Clinical Trial of Lithium Carbonate Combined With Neo-adjuvent Chemotherapy to Treat Osteosarcoma", 
        "overall_contact": {
            "email": "2004wjhf@163.com", 
            "last_name": "Jin Wang, PhD", 
            "phone": "+86-20-87755766", 
            "phone_ext": "8236"
        }, 
        "overall_official": {
            "affiliation": "First Affiliated Hospital, Sun Yat-Sen University", 
            "last_name": "Jin Wang, PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "December 2023", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "progression-free survival,incidence of chemotherapy-induced myelosuppression", 
            "safety_issue": "Yes"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01669369"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Sun Yat-sen University", 
            "investigator_full_name": "Jin Wang", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "measure": "over-all survival,metastasis-free survival", 
            "safety_issue": "No"
        }, 
        "source": "Sun Yat-sen University", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Qilu Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Nanfang Hospital of Southern Medical University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Guangdong Provincial Hospital of Traditional Chinese Medicine", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Shenzhen Second People's Hospital, The First Affiliated Hospital of Shenzhen University", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Shanghai 6th People's Hospital", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Sun Yat-sen University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 2012"
    }
}